FDA 483 - Rush University Medical Center IRB - December 21, 2005

An FDA inspection of Rush University Medical Center IRB in Chicago revealed several deficiencies in its oversight of human subject research. The IRB failed to follow its own written procedures for continuing review, maintained inadequate meeting minutes, and approved research without ensuring proper informed consent. These findings indicate a need for improved controls in protecting human subjects.